跳至主要内容
临床试验/NCT02026752
NCT02026752已完成不适用

Collection of Plasma Samples From Human Immunodeficiency Virus (HIV) Type 1 (HIV-1) Infected Individuals for the Clinical Evaluation of the Aptima HIV-1 Quant Dx Assay

Gen-Probe, Incorporated9 个研究点 分布在 1 个国家目标入组 468 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
468
试验地点
9
主要终点
Quantitative detection of HIV-1 RNA

研究概览

简要总结

The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. The plasma samples will be tested in a method comparison study to support the approval of the Aptima HIV-1 assay on Gen-Probe's Panther testing system. The objective of the method comparison study is to evaluate the clinical utility of the Aptima HIV-1 assay by comparing the results to the FDA-licensed COBAS assay (Roche Molecular Systems, Inc., Branchburg, New Jersey) in plasma samples that have viral loads across the dynamic range of the Aptima HIV-1 assay.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Quantitative detection of HIV-1 RNA

时间窗: single baseline visit

Regression parameters (intercept and slope) will be estimated from method comparison analysis.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (9)

Loading locations...

相似试验